Disclosures for "REMEDY: A Novel CRISPR-based Allele Specific Approach Corrects VCP Mutations "
-
Dr. D'Ambrosio has nothing to disclose.
-
Dr. Ozes has nothing to disclose.
-
Dr. Sahenk has nothing to disclose.
-
Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
-
The institution of Dr. Naeimi Kararoudi has received research support from Metagenomi. Dr. Naeimi Kararoudi has received intellectual property interests from a discovery or technology relating to health care.